Pinkerton Retirement Specialists’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,762
Closed -$290K 147
2023
Q2
$290K Sell
3,762
-941
-20% -$75K 0.06% 124
2023
Q1
$390K Buy
4,703
+129
+3% +$10.7K 0.07% 115
2022
Q4
$393K Buy
+4,574
New +$362K 0.09% 96
2018
Q1
Sell
-300
Closed -$22K 182
2017
Q4
$22K Buy
+300
New +$22.8K 0.01% 128
2017
Q1
Sell
-1,551
Closed -$111K 267
2016
Q4
$111K Sell
1,551
-17
-1% -$1.26K 0.05% 152
2016
Q3
$124K Sell
1,568
-31
-2% -$2.52K 0.05% 148
2016
Q2
$133K Buy
1,599
+1,582
+9,306% +$140K 0.07% 121
2016
Q1
$4K Sell
17
-47
-73% -$4.24K ﹤0.01% 136
2015
Q4
$6K Hold
64
﹤0.01% 101
2015
Q3
$6K Hold
64
0.01% 101
2015
Q2
$7K Buy
+64
New +$6.99K ﹤0.01% 108

Other funds holding GILD

Pinkerton Retirement Specialists's GILD Position: Q3 2023 in Review

Pinkerton Retirement Specialists sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 3,762 shares — an estimated $290K sold.

Pinkerton Retirement Specialists first reported a position in GILD in Q2 2015 and held it in 11 quarters. The position peaked at $393K in Q4 2022. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Pinkerton Retirement Specialists reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 3,762 Gilead Sciences shares in Q3 2023, an estimated $290K.
  • Pinkerton Retirement Specialists first reported a position in Gilead Sciences in Q2 2015 and held it in 11 quarters.
  • Pinkerton Retirement Specialists's Gilead Sciences position peaked at $393K in Q4 2022.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Pinkerton Retirement Specialists's 13F filing for Q3 2023, filed 13 Nov 2023.